Terms: = Skin cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
45 results:
1. TNF and IFNγ-induced cell death requires IRF1 and ELAVL1 to promote casp8 expression.
Deng B; Wang J; Yang T; Deng Z; Yuan J; Zhang B; Zhou Z; Chen F; Fang L; Liang C; Yan B; Ai Y
J Cell Biol; 2024 Mar; 223(3):. PubMed ID: 38319288
[TBL] [Abstract] [Full Text] [Related]
2. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
Camera S; Rimini M; Rossari F; Tada T; Suda G; Shimose S; Kudo M; Yoo C; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Bergamo F; Salani F; Marseglia M; Amadeo E; Vitiello F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Iavarone M; Cabibbo G; Montes M; Foschi FG; Vivaldi C; Lonardi S; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Hiraoka A; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Foti S; Piscaglia F; Scartozzi M; Cascinu S; Casadei-Gardini A
Target Oncol; 2024 Jan; 19(1):29-39. PubMed ID: 38252195
[TBL] [Abstract] [Full Text] [Related]
3. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract] [Full Text] [Related]
4. Herniarin-loaded solid lipid nanoparticles: promising molecular mechanism and therapeutic potential against pancreatic cancer line.
Delkhah AMD; Karimi E; Farivar S
Mol Biol Rep; 2023 Aug; 50(8):6469-6479. PubMed ID: 37326747
[TBL] [Abstract] [Full Text] [Related]
5. Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related casp8/CASP3/NLRP3 genes in human metastatic melanoma cells.
da Silva GB; Manica D; da Silva AP; Marafon F; Moreno M; Bagatini MD
Chem Biol Interact; 2023 Apr; 375():110427. PubMed ID: 36863647
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
[No Abstract] [Full Text] [Related]
7. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
Hong JY; Ahn J; Won S; Kim SM; Cho YA; Kim CY; Sung JY; Yu DA; Lee YW; Choe YB
Sci Rep; 2022 Nov; 12(1):20690. PubMed ID: 36450739
[TBL] [Abstract] [Full Text] [Related]
8. PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis.
He R; Zhao X; Liu J; Zhou Y; Zhang X; Cheng F
Medicine (Baltimore); 2022 Oct; 101(41):e30561. PubMed ID: 36254050
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
Lin EP; Hsu CY; Berry L; Bunn P; Shyr Y
JAMA Netw Open; 2022 Aug; 5(8):e2227211. PubMed ID: 35976648
[TBL] [Abstract] [Full Text] [Related]
10. The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis.
Cui Y; Guo Y
Int J Clin Pharm; 2022 Aug; 44(4):843-851. PubMed ID: 35750983
[TBL] [Abstract] [Full Text] [Related]
11. Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.
Schuler M; Zimmer L; Kim KB; Sosman JA; Ascierto PA; Postow MA; De Vos FYFL; van Herpen CML; Carlino MS; Johnson DB; Berking C; Reddy MB; Harney AS; Berlin JD; Amaria RN
Clin Cancer Res; 2022 Jul; 28(14):3002-3010. PubMed ID: 35294522
[TBL] [Abstract] [Full Text] [Related]
12. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
[TBL] [Abstract] [Full Text] [Related]
13. Cytotoxic effects on cancerous and non-cancerous cells of trans-cinnamaldehyde, carvacrol, and eugenol.
Ranjitkar S; Zhang D; Sun F; Salman S; He W; Venkitanarayanan K; Tulman ER; Tian X
Sci Rep; 2021 Aug; 11(1):16281. PubMed ID: 34381064
[TBL] [Abstract] [Full Text] [Related]
14. Monitoring real-life utilization of pembrolizumab in advanced melanoma using the Portuguese National cancer Registry.
Borges FC; Ramos C; Ramos A; Mendes GP; Murteira R; Soares P; Furtado C; Miranda AC; Costa FA;
Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):342-349. PubMed ID: 33103788
[TBL] [Abstract] [Full Text] [Related]
15. Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.
Moser JC; Wei G; Colonna SV; Grossmann KF; Patel S; Hyngstrom JR
Acta Oncol; 2020 Apr; 59(4):434-437. PubMed ID: 31920132
[No Abstract] [Full Text] [Related]
16. Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study.
Simon TA; Boers M; Hochberg M; Baker N; Skovron ML; Ray N; Singhal S; Suissa S; Gomez-Caminero A
Arthritis Res Ther; 2019 Nov; 21(1):228. PubMed ID: 31703717
[TBL] [Abstract] [Full Text] [Related]
17. Ethanol extract of asiasari radix preferentially induces apoptosis in G361 human melanoma cells by differential regulation of p53.
Park KH; Choi JH; Song YS; Kim GC; Hong JW
BMC Complement Altern Med; 2019 Aug; 19(1):231. PubMed ID: 31462222
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis.
Heppt MV; Steeb T; Leiter U; Berking C
J Eur Acad Dermatol Venereol; 2019 May; 33(5):863-873. PubMed ID: 30710390
[TBL] [Abstract] [Full Text] [Related]
19. Primary cutaneous B-cell lymphoma: A single-center 5-year experience.
Jacob LA; Asati V; Lakshmaiah KC; Govind BK; Lokanatha D; Babu SM; Lokesh KN; Rudresh AH; Rajeev LK; Mulchandani NJ; Anand A; Koppaka D; Mysore SN
Indian J Cancer; 2018; 55(2):134-137. PubMed ID: 30604723
[TBL] [Abstract] [Full Text] [Related]
20. Multiple sclerosis and cancer incidence: A Danish nationwide cohort study.
Nørgaard M; Veres K; Didden EM; Wormser D; Magyari M
Mult Scler Relat Disord; 2019 Feb; 28():81-85. PubMed ID: 30576846
[TBL] [Abstract] [Full Text] [Related]
[Next]
